109 results on '"Anna Maria Giusti"'
Search Results
2. ROCKETS – a novel one-for-all toolbox for light sheet microscopy in drug discovery
- Author
-
Joerg P. J. Mueller, Michael Dobosz, Nils O’Brien, Nassri Abdoush, Anna Maria Giusti, Martin Lechmann, Franz Osl, Ann-Katrin Wolf, Estibaliz Arellano-Viera, Haroon Shaikh, Markus Sauer, Andreas Rosenwald, Frank Herting, Pablo Umaña, Sara Colombetti, Thomas Pöschinger, and Andreas Beilhack
- Subjects
imaging ,immunotherapy ,preclinical drug development ,biodistribution ,cancer ,light sheet fluorescence microscopy ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Advancing novel immunotherapy strategies requires refined tools in preclinical research to thoroughly assess drug targets, biodistribution, safety, and efficacy. Light sheet fluorescence microscopy (LSFM) offers unprecedented fast volumetric ex vivo imaging of large tissue samples in high resolution. Yet, to date laborious and unstandardized tissue processing procedures have limited throughput and broader applications in immunological research. Therefore, we developed a simple and harmonized protocol for processing, clearing and imaging of all mouse organs and even entire mouse bodies. Applying this Rapid Optical Clearing Kit for Enhanced Tissue Scanning (ROCKETS) in combination with LSFM allowed us to comprehensively study the in vivo biodistribution of an antibody targeting Epithelial Cell Adhesion Molecule (EpCAM) in 3D. Quantitative high-resolution scans of whole organs did not only reveal known EpCAM expression patterns but, importantly, uncovered several new EpCAM-binding sites. We identified gustatory papillae of the tongue, choroid plexi in the brain and duodenal papillae as previously unanticipated locations of high EpCAM expression. Subsequently, we confirmed high EpCAM expression also in human tongue and duodenal specimens. Choroid plexi and duodenal papillae may be considered as particularly sensitive sites due to their importance for liquor production or as critical junctions draining bile and digestive pancreatic enzymes into the small bowel, respectively. These newly gained insights appear highly relevant for clinical translation of EpCAM-addressing immunotherapies. Thus, ROCKETS in combination with LSFM may help to set new standards for preclinical evaluation of immunotherapeutic strategies. In conclusion, we propose ROCKETS as an ideal platform for a broader application of LSFM in immunological research optimally suited for quantitative co-localization studies of immunotherapeutic drugs and defined cell populations in the microanatomical context of organs or even whole mice.
- Published
- 2023
- Full Text
- View/download PDF
3. JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy
- Author
-
Christian Klein, Marina Bacac, Pablo Umana, Martin Stern, Gabrielle Leclercq, Hélène Haegel, Anneliese Schneider, Anna Maria Giusti, Vesna Pulko, Johannes Sam, John Challier, Alex Odermatt, Luke Green, Alberto Toso, Tina Zimmermann, Nathalie Steinhoff, Anne Freimoser-Grundschober, and Laurent Larivière
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2022
- Full Text
- View/download PDF
4. Impact of Disability, Psychological Status, and Comorbidity on Health-Related Quality of Life Perceived by Subjects with Obesity
- Author
-
Lorenzo Maria Donini, Aldo Rosano, Luca Di Lazzaro, Carla Lubrano, Mariagrazia Carbonelli, Alessandro Pinto, Anna Maria Giusti, Andrea Lenzi, and Mario Siervo
- Subjects
quality of life ,obesity ,disability ,Nutrition. Foods and food supply ,TX341-641 ,Nutritional diseases. Deficiency diseases ,RC620-627 - Abstract
Obesity is a rapidly growing public health problem affecting an increasing number of countries worldwide and creating substantial financial and health burdens. Obesity has a negative impact on health-related quality of life (HRQoL) with reference to physical and mental health status, social relationships, and economic factors. The aim of the present study is to investigate the association of number of comorbidities, psychological status, and disability level with HRQoL in a sample of subjects with obesity. Methods: A total of 273 subjects with obesity (199 women and 74 men) were recruited. Medical history and anthropometric measurements were carried out. The Italian version of the Laval questionnaire, the TSD-OC (SIO test for obesity-related disabilities), and SCL-90 (Symptom Checklist-90) tests were administered. The association between HRQoL (global and different domains scores of the Laval questionnaire – dependent variable) and age, body mass index (BMI), comorbidity, TSD-OC, and SCL-90 was analysed using a stepwise linear regression model. Results: BMI, disability (TSD-OC global score), and psychological symptoms (SCL-90 global severity index) were found to be the main determinants of HRQoL. Single domains of HRQoL (symptoms, activity/mobility, personal hygiene/clothing, emotions, social interaction, and sexual life) showed different patterns of associations with each domain of the Laval questionnaire. BMI, pain, and social life disruptions were found to be significantly associated with most of the HRQoL domains while age, comorbidities, psychological problems (depression, interpersonal symptoms, somatization), and disability were associated with only some domains of the Laval questionnaire. Education, psychological symptoms (obsessive-compulsive, anxiety, hostility, phobic anxiety, paranoid ideation), and disability domains (stiffness, housework, outdoor activities, occupational activities) were not associated with any of the dimensions of the Laval questionnaire. Discussion/Conclusion: The present study identified key determinants of QoL in subjects with obesity, which could help in refining the multidimensional diagnostic assessment of obesity as well as designing more effective interventions to improve HRQoL in these patients.
- Published
- 2020
- Full Text
- View/download PDF
5. Industrial Hemp (Cannabis sativa L.) Inflorescences as Novel Food: The Effect of Different Agronomical Practices on Chemical Profile
- Author
-
Mattia Spano, Giacomo Di Matteo, Cinzia Ingallina, Anatoly Petrovich Sobolev, Anna Maria Giusti, Giuliana Vinci, Silvia Cammarone, Carola Tortora, Lara Lamelza, Sabrina Antonia Prencipe, Laura Gobbi, Bruno Botta, Federico Marini, Enio Campiglia, and Luisa Mannina
- Subjects
industrial hemp ,agronomical practices ,fertilization ,harvesting ,chemical profile ,Chemical technology ,TP1-1185 - Abstract
In this study, the effect of several agronomical practices on the chemical composition of hemp inflorescences, a potential novel food that needs to be further studied, was observed. Here, the case study of inflorescences from Ferimon cultivars is discussed and submitted to different agronomical practices (irrigation and fertilizers) in different years, and the inflorescences harvested in different periods were analyzed by a multimethodological approach. Targeted and untargeted methodologies allowed cannabinoids, total phenolic content, metabolite profile and antioxidant activity to be determined. The biomass and inflorescence yields were also reported. The whole data set was submitted to ANOVA-simultaneous component analysis. The statistic results allowed us to observe that irrigation was responsible for the (–)-Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) increment. THC, cannabichromene (CBC), cannabigerol (CBG), succinate, and fructose resulted as higher in full female flowering than in the period of seed maturity. On the other hand, nitrogen supplementation led to an increase of iso-leucine, valine, and threonine. The obtained results underlined both the potential food application of hemp inflorescences, due to the rich chemical profile, and the strong effect of agronomical practices, mainly irrigation and harvesting, on the qualitative and quantitative characteristics of its metabolite profile.
- Published
- 2022
- Full Text
- View/download PDF
6. Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies
- Author
-
S Jordan Kerns, Chaitra Belgur, Debora Petropolis, Marianne Kanellias, Riccardo Barrile, Johannes Sam, Tina Weinzierl, Tanja Fauti, Anne Freimoser-Grundschober, Jan Eckmann, Carina Hage, Martina Geiger, Patrick Ray Ng, William Tien-Street, Dimitris V Manatakis, Virginie Micallef, Regine Gerard, Michael Bscheider, Ekaterina Breous-Nystrom, Anneliese Schneider, Anna Maria Giusti, Cristina Bertinetti-Lapatki, Heather Shannon Grant, Adrian B Roth, Geraldine A Hamilton, Thomas Singer, Katia Karalis, Annie Moisan, Peter Bruenker, Christian Klein, Marina Bacac, Nikolce Gjorevski, and Lauriane Cabon
- Subjects
organs-on-chips ,t-cell bispecifics ,cancer immunotherapy ,preclinical safety ,alveolar biology ,intestinal biology ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Traditional drug safety assessment often fails to predict complications in humans, especially when the drug targets the immune system. Here, we show the unprecedented capability of two human Organs-on-Chips to evaluate the safety profile of T-cell bispecific antibodies (TCBs) targeting tumor antigens. Although promising for cancer immunotherapy, TCBs are associated with an on-target, off-tumor risk due to low levels of expression of tumor antigens in healthy tissues. We leveraged in vivo target expression and toxicity data of TCBs targeting folate receptor 1 (FOLR1) or carcinoembryonic antigen (CEA) to design and validate human immunocompetent Organs-on-Chips safety platforms. We discovered that the Lung-Chip and Intestine-Chip could reproduce and predict target-dependent TCB safety liabilities, based on sensitivity to key determinants thereof, such as target expression and antibody affinity. These novel tools broaden the research options available for mechanistic understandings of engineered therapeutic antibodies and assessing safety in tissues susceptible to adverse events.
- Published
- 2021
- Full Text
- View/download PDF
7. Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies
- Author
-
Christian Klein, Marina Bacac, Pablo Umana, Gabrielle Leclercq, Hélène Haegel, Anneliese Schneider, Anna Maria Giusti, Estelle Marrer-Berger, Christophe Boetsch, Antje-Christine Walz, Vesna Pulko, Johannes Sam, John Challier, Cristiano Ferlini, and Alex Odermatt
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background T cell engagers are bispecific antibodies recognizing, with one moiety, the CD3ε chain of the T cell receptor and, with the other moiety, specific tumor surface antigens. Crosslinking of CD3 upon simultaneous binding to tumor antigens triggers T cell activation, proliferation and cytokine release, leading to tumor cell killing. Treatment with T cell engagers can be associated with safety liabilities due to on-target on-tumor, on-target off-tumor cytotoxic activity and cytokine release syndrome (CRS). Tyrosine kinases such as SRC, LCK or ZAP70 are involved in downstream signaling pathways after engagement of the T cell receptor and blocking these kinases might serve to abrogate T cell activation when required (online supplemental material 1). Dasatinib was previously identified as a potent kinase inhibitor that switches off CAR T cell functionality.Methods Using an in vitro model of target cell killing by human peripheral blood mononuclear cells, we assessed the effects of dasatinib combined with 2+1 T cell bispecific antibodies (TCBs) including CEA-TCB, CD19-TCB or HLA-A2 WT1-TCB on T cell activation, proliferation and target cell killing measured by flow cytometry and cytokine release measured by Luminex. To determine the effective dose of dasatinib, the Incucyte system was used to monitor the kinetics of TCB-mediated target cell killing in the presence of escalating concentrations of dasatinib. Last, the effects of dasatinib were evaluated in vivo in humanized NSG mice co-treated with CD19-TCB. The count of CD20+ blood B cells was used as a readout of efficacy of TCB-mediated killing and cytokine levels were measured in the serum.Results Dasatinib concentrations above 50 nM prevented cytokine release and switched off-target cell killing, which were subsequently restored on removal of dasatinib. In addition, dasatinib prevented CD19-TCB-mediated B cell depletion in humanized NSG mice. These data confirm that dasatinib can act as a rapid and reversible on/off switch for activated T cells at pharmacologically relevant doses as they are applied in patients according to the label.Conclusion Taken together, we provide evidence for the use of dasatinib as a pharmacological on/off switch to mitigate off-tumor toxicities or CRS by T cell bispecific antibodies.
- Published
- 2021
- Full Text
- View/download PDF
8. Obesity or BMI Paradox? Beneath the Tip of the Iceberg
- Author
-
Lorenzo Maria Donini, Alessandro Pinto, Anna Maria Giusti, Andrea Lenzi, and Eleonora Poggiogalle
- Subjects
obesity ,obesity paradox ,nutritional status ,body composition ,body mass index ,Nutrition. Foods and food supply ,TX341-641 - Abstract
The obesity paradox refers to extant evidence showing that obesity in older subjects or in patients with several chronic diseases may be protective and associated with decreased mortality. A number of mechanisms have been postulated to support the existence of obesity paradox; however, marked heterogeneity was found across studies and this has cast doubt on the actual presence of this phenomenon. The aim of the present narrative review is to summarize evidence underlying the concept of obesity paradox, focusing on limitations and bias related to this phenomenon, with emphasis on the use of body mass index (BMI). A major cause of the discrepancy between studies may be related to the use of BMI in the definition of obesity, that should consider, instead, excess body fat as the main characteristic of this disease and as the unique determinant of its complications. In addition, the adjustment for potential confounders (e.g., stage and grade of diseases, smoking habit, inability to capture the presence of signs of undernutrition in the normal-weight comparative group, consideration of body composition) may significantly scale down the protective role of obesity in terms of mortality. However, it is still necessary to acknowledge few biases (e.g., reverse causation, attrition bias, selection bias of healthy obese subjects or resilient survivors) that would still apply to obesity even when defined according with body composition. Further research should be prompted in order to promote correct phenotyping of patients in order to capture properly the trajectories of mortality in a number of diseases.
- Published
- 2020
- Full Text
- View/download PDF
9. Characterization of the Phytochemical Composition and Bioactivities of Anacyclus maroccanus Ball. and Anacyclus radiatus Loisel Aerial Parts: Preliminary Evidence for the Possible Development of Moroccan Plants
- Author
-
Saida Sissi, Silvia Di Giacomo, Claudio Ferrante, Paola Angelini, Alberto Macone, Anna Maria Giusti, Chiara Toniolo, Annabella Vitalone, Aghraz Abdellah, Mustapha Larhsini, Luigi Menghini, Mohammed Markouk, Gabriela Mazzanti, and Antonella Di Sotto
- Subjects
phenolics ,hypoglycemic activity ,α-glucosidase ,antiglycation activity ,chelating activity ,advanced glycation end products ,Organic chemistry ,QD241-441 - Abstract
In the present study, the phytochemical composition and bioactivities of A. maroccanus (AM) and A. radiatus (AR), two ecotypes collected in the Demnate road and Essaouira regions, respectively, were studied to highlight a pharmacological interest and to enable possible pharmaceutical development. To this end, methanolic and ethyl acetate extracts were prepared for each ecotype by fractionation; next, their phytochemical composition was evaluated by spectrophotometric and chromatographic analysis. Moreover, in line with the available evidence for Anacyclus spp. and their traditional use, a screening of bioactivities, including antioxidant, hypoglycemic, antiglycative, chelating, and antibacterial activities, was performed. The extracts were characterized by high amounts of polyphenols, tannins, and flavonoids, especially in the methanolic extracts; these samples were also enriched in carotenoids despite a lower chlorophyll content. Chlorogenic acid and rutin were the major identified compounds. The extracts also showed interesting hypoglycemic, antiglycative, and antibacterial properties, although with differences in efficacy and potency. Present results provide more scientific basis to the ethnopharmacological uses of Anacyclus spp. and suggest a further interest in AM and AR ecotypes as natural sources of bioactive compounds and/or phytocomplexes for possible pharmaceutical and nutraceutical developments.
- Published
- 2022
- Full Text
- View/download PDF
10. Capsicum annuum L. var. Cornetto di Pontecorvo PDO: Polyphenolic profile and in vitro biological activities
- Author
-
Antonella Di Sotto, Martina Vecchiato, Lorena Abete, Chiara Toniolo, Anna Maria Giusti, Luisa Mannina, Marcello Locatelli, Marcello Nicoletti, and Silvia Di Giacomo
- Subjects
Antimutagenic activity ,Oxidative stress ,Chelating activity ,Hyperglycemia ,Carvacrol ,Nutrition. Foods and food supply ,TX341-641 - Abstract
In present study, the potential functional properties of the ethanolic extracts from peel, pulp, edible part and seeds of Capsicum annuum L. var. Cornetto di Pontecorvo were studied. The antimutagenicity against environmental pollutants and oxidative mutagens, the digestive enzyme inhibition, and the antioxidant properties were evaluated in relation to phenolic content. All the samples produced antimutagenic effects against 1-nitropyrene, 2-aminoantracene and tert-butyl-hydroperoxide, and inhibited α-amylase, without affecting α-glucosidase. Also, radical scavenging effects, inhibition of ROS-mediated lipoperoxidation and chelating activity were highlighted. The peel and seed extracts were in general the most effective samples. The phytochemical analysis highlighted a high amount of polyphenols, with a very low carotenoid content. Among phenolics, rutin, gallic acid, carvacrol, chlorogenic acid, 4-OH benzoic acid, and traces of quercetin and epicatechin were determined. Present results highlight a functional role of this pepper ecotype and suggest a possible use of its derived products as food supplements.
- Published
- 2018
- Full Text
- View/download PDF
11. Commercial Bio-Packaging to Preserve the Quality and Extend the Shelf-Life of Vegetables: The Case-Study of Pumpkin Samples Studied by a Multimethodological Approach
- Author
-
Giacomo Di Matteo, Paola Di Matteo, Matteo Sambucci, Jacopo Tirillò, Anna Maria Giusti, Giuliana Vinci, Laura Gobbi, Sabrina Antonia Prencipe, Andrea Salvo, Cinzia Ingallina, Mattia Spano, Anatoly P. Sobolev, Noemi Proietti, Valeria Di Tullio, Paola Russo, Luisa Mannina, and Marco Valente
- Subjects
pumpkin ,biofilm ,shelf life ,metabolomics ,NMR spectroscopy ,NMR relaxometry ,Chemical technology ,TP1-1185 - Abstract
A multidisciplinary protocol is proposed to monitor the preservation of fresh pumpkin samples (FP) using three commercial polymeric films: A made of biodegradable cellophane from regenerated cellulose pulp; B from corn starch, cassava and eucalyptus, C made of polylactic acid from corn starch, and a polyethylene film used as reference (REF). Chemical, mechanical and microbiological analyses were applied on packaging and fresh and packaged samples at different times. After an 11-day period, NMR spectroscopy results showed a sucrose increase and a malic acid decrease in all the biofilms with respect to FP; fructose, glucose, galactose levels remained quite constant in biofilms B and C; the most abundant amino acids remained quite constant in biofilm A and decreased significantly in biofilm B. From microbiological analyses total microbial count was below the threshold value up to 7 days for samples in all the films, and 11 days for biofilm C. The lactic acid bacteria, and yeasts and molds counts were below the acceptability limit during the 11 days for all packages. In the case of biofilm C, the most promising packaging for microbiological point of view, aroma analysis was also carried out. In this paper, you can find all the analysis performed and all the values found.
- Published
- 2021
- Full Text
- View/download PDF
12. Metabolomic Profiling of Fresh Goji (Lycium barbarum L.) Berries from Two Cultivars Grown in Central Italy: A Multi-Methodological Approach
- Author
-
Mattia Spano, Alessandro Maccelli, Giacomo Di Matteo, Cinzia Ingallina, Mariangela Biava, Maria Elisa Crestoni, Jean-Xavier Bardaud, Anna Maria Giusti, Alessia Mariano, Anna Scotto D’Abusco, Anatoly P. Sobolev, Alba Lasalvia, Simonetta Fornarini, and Luisa Mannina
- Subjects
Goji berries ,metabolite profile ,NMR ,FT-ICR MS ,Goji leaves ,biological assays ,Organic chemistry ,QD241-441 - Abstract
The metabolite profile of fresh Goji berries from two cultivars, namely Big Lifeberry (BL) and Sweet Lifeberry (SL), grown in the Lazio region (Central Italy) and harvested at two different periods, August and October, corresponding at the beginning and the end of the maturation, was characterized by means of nuclear magnetic resonance (NMR) and electrospray ionization Fourier transform ion cyclotron resonance (ESI FT-ICR MS) methodologies. Several classes of compounds such as sugars, amino acids, organic acids, fatty acids, polyphenols, and terpenes were identified and quantified in hydroalcoholic and organic Bligh-Dyer extracts. Sweet Lifeberry extracts were characterized by a higher content of sucrose with respect to the Big Lifeberry ones and high levels of amino acids (glycine, betaine, proline) were observed in SL berries harvested in October. Spectrophotometric analysis of chlorophylls and total carotenoids was also carried out, showing a decrease of carotenoids during the time. These results can be useful not only to valorize local products but also to suggest the best harvesting period to obtain a product with a chemical composition suitable for specific industrial use. Finally, preliminary studies regarding both the chemical characterization of Goji leaves generally considered a waste product, and the biological activity of Big Lifeberry berries extracts was also investigated. Goji leaves showed a chemical profile rich in healthy compounds (polyphenols, flavonoids, etc.) confirming their promising use in the supplements/nutraceutical/cosmetic field. MG63 cells treated with Big Lifeberry berries extracts showed a decrease of iNOS, COX-2, IL-6, and IL-8 expression indicating their significant biological activity.
- Published
- 2021
- Full Text
- View/download PDF
13. A Multimethodological Characterization of Cannabis sativa L. Inflorescences from Seven Dioecious Cultivars Grown in Italy: The Effect of Different Harvesting Stages
- Author
-
Mattia Spano, Giacomo Di Matteo, Cinzia Ingallina, Bruno Botta, Deborah Quaglio, Francesca Ghirga, Silvia Balducci, Silvia Cammarone, Enio Campiglia, Anna Maria Giusti, Giuliana Vinci, Mattia Rapa, Salvatore Ciano, Luisa Mannina, and Anatoly P. Sobolev
- Subjects
industrial hemp ,dioecious cultivars ,inflorescences ,phenological growth stages ,cannabinoids ,metabolite profile ,Organic chemistry ,QD241-441 - Abstract
The chemical profile of the female inflorescence extracts from seven Cannabis sativa L. dioecious cultivars (Carmagnola, Fibranova, Eletta Campana, Antal, Tiborszallasi, Kompolti, and Tisza) was monitored at three harvesting stages (4, 14, and 30 September), reaching from the beginning of flowering to end of flowering/beginning of seed formation, using untargeted nuclear magnetic resonance (NMR) and targeted (ultra-high-performance liquid chromatography (UHPLC) and spectrophotometry) analyses. The tetrahydrocannabinol content was always below the legal limits (Cannabis sativa L. inflorescences of each analyzed dioecious hemp cultivar presented a peculiar chemical profile affected by the harvesting stage. This information could be useful for producers and industries to harvest inflorescences in the appropriate stage to obtain samples with a peculiar chemical profile suitable for proper applications.
- Published
- 2021
- Full Text
- View/download PDF
14. Influence of dietary vitamin E supplementation on cholesterol oxidation and fresh colour in beef aged for 3 and 14 days
- Author
-
Federico Vincenti, Anna Maria Giusti, Pier Paolo Danieli, Bruno Ronchi, Francesca Perer, Alberto Macone, Emanuela Filippi, and Miriam Iacurto
- Subjects
beef cattle ,cops ,lipid oxidation ,meat colour ,shelf life ,vitamin e ,Animal culture ,SF1-1100 - Abstract
The effects of dietary vitamin E supplementation on the susceptibility to lipid oxidation and colour of the Longissimus thoracis (LT) muscle aged in vacuum packaged conditions for 3 or 14 days were studied. For this purpose, Charolais cattle were fed on a diet providing daily 60 mg (control) or 5500 mg of vitamin E per animal (supplemented) for 30 and 60 days before slaughter. Dietary vitamin E supplementation increased the liver vitamin E content, but not in the LT muscle of treated animals. The vitamin supplementation for 30 and 60 days has shown non-consistent effects in reducing cholesterol oxidation products of vacuum-packed aged meat. However, the vitamin E supplementation for 60 days was effective on Lightness stability in LT muscle during vacuum-packed ageing. Overall, from the practical standpoint, this study suggests that supra-nutritional supplementation up to 60 days may not increase the vitamin E content of Charolais LT muscle giving little, if any, benefits on meat colour and cholesterol oxidation. However, the present study suggests that it would be interesting to determine in which extent specific oxy-sterols are related to the meat colour and whether colour parameters can be useful for predicting the formation of cholesterol oxidation products along the industrial meat production chain.
- Published
- 2016
- Full Text
- View/download PDF
15. Commercial Hemp Seed Oils: A Multimethodological Characterization
- Author
-
Mattia Spano, Giacomo Di Matteo, Mattia Rapa, Salvatore Ciano, Cinzia Ingallina, Stefania Cesa, Luigi Menghini, Simone Carradori, Anna Maria Giusti, Antonella Di Sotto, Silvia Di Giacomo, Anatoly P. Sobolev, Giuliana Vinci, and Luisa Mannina
- Subjects
hemp seed oil ,quality parameters ,NMR ,colorimetric analysis ,lipoperoxidation ,Technology ,Engineering (General). Civil engineering (General) ,TA1-2040 ,Biology (General) ,QH301-705.5 ,Physics ,QC1-999 ,Chemistry ,QD1-999 - Abstract
Nine commercial hemp seed oils from different countries were studied using a multimethodological approach to obtain information about their quality and chemical composition. Due to the lack of a specific regulation for hemp seed oils, quality parameters used in the case of olive oils (free acidity, peroxides number, spectrophotometer parameters) and anisidine number were measured and compared with those reported for extra virgin olive oil (EVOO). Free acidity and peroxides number showed a great variability, ranging from 0.4 to 17.24% and from 4.32 to 22.14 meqO2/kg, respectively, whereas the anisidine number ranged from 0.11 to 3.58. K232 value turned out to be generally below the limit reported for EVOO, whereas K270 and ΔK values were higher, with respect to EVOO limits, due to the high amount of tri-unsaturated fatty chains. Colorimetric analysis showed a peculiar curve trend that could represent the fingerprint of this product. Untargeted nuclear magnetic resonance methodology allowed to measure the amount of fatty chains, ω-6:ω-3 ratio, β-sitosterol, and aldehydes. The ω-6:ω-3 ratio turned out to be, in some cases, different from that reported on the bottle labels. Finally, lipoperoxidation assays were also carried out under different storage (light and temperature) and time exposure conditions, confirming that the exposure to direct light is the condition that interferes more with the product quality.
- Published
- 2020
- Full Text
- View/download PDF
16. Chemico-Biological Characterization of Torpedino Di Fondi® Tomato Fruits: A Comparison with San Marzano Cultivar at Two Ripeness Stages
- Author
-
Cinzia Ingallina, Alessandro Maccelli, Mattia Spano, Giacomo Di Matteo, Antonella Di Sotto, Anna Maria Giusti, Giuliana Vinci, Silvia Di Giacomo, Mattia Rapa, Salvatore Ciano, Caterina Fraschetti, Antonello Filippi, Giovanna Simonetti, Carlos Cordeiro, Marta Sousa Silva, Maria Elisa Crestoni, Anatoly P. Sobolev, Simonetta Fornarini, and Luisa Mannina
- Subjects
tomatoes ,NMR spectroscopy ,FT-ICR mass spectrometry ,ripening stage ,phenolics ,antioxidant activity ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Torpedino di Fondi (TF) is a hybrid tomato landrace developed in Sicily and recently introduced in the south Lazio area along with the classical San Marzano (SM) cultivar. The present study aimed at characterizing TF tomatoes at both pink and red ripening stages, and at comparing them with traditional SM tomatoes. A multidisciplinary approach consisting of morphological, chemical (FT-ICR MS, NMR, HPLC, and spectrophotometric methods), and biological (antioxidant and antifungal in vitro activity) analyses was applied. Morphological analysis confirmed the mini-San Marzano nature and the peculiar crunchy and solid consistency of TF fruits. Pink TF tomatoes displayed the highest content of hydrophilic antioxidants, like total polyphenols (0.192 mg/g), tannins (0.013 mg/g), flavonoids (0.204 mg/g), and chlorophylls a (0.344 mg/g) and b (0.161 mg/g), whereas red TF fruits were characterized by the highest levels of fructose (3000 mg/100 g), glucose (2000 mg/100 g), tryptophan (2.7 mg/100 g), phenylalanine (13 mg/100 g), alanine (25 mg/100 g), and total tri-unsaturated fatty acids (13% mol). Red SM fruits revealed the greatest content of lipophilic antioxidants, with 1234 mg/g of total carotenoids. In agreement with phenolics content, TF cultivar showed the greatest antioxidant activity. Lastly, red TF inhibited Candida species (albicans, glabrata and krusei) growth.
- Published
- 2020
- Full Text
- View/download PDF
17. Cannabis sativa L. Inflorescences from Monoecious Cultivars Grown in Central Italy: An Untargeted Chemical Characterization from Early Flowering to Ripening
- Author
-
Cinzia Ingallina, Anatoly P. Sobolev, Simone Circi, Mattia Spano, Caterina Fraschetti, Antonello Filippi, Antonella Di Sotto, Silvia Di Giacomo, Giulia Mazzoccanti, Francesco Gasparrini, Deborah Quaglio, Enio Campiglia, Simone Carradori, Marcello Locatelli, Giuliana Vinci, Mattia Rapa, Salvatore Ciano, Anna Maria Giusti, Bruno Botta, Francesca Ghirga, Donatella Capitani, and Luisa Mannina
- Subjects
Cannabis sativa L. ,monoecious cultivars ,inflorescences ,cannabinoids ,metabolic profile ,multimethodological analysis ,Organic chemistry ,QD241-441 - Abstract
The chemical composition of the inflorescences from four Cannabis sativa L. monoecious cultivars (Ferimon, Uso-31, Felina 32 and Fedora 17), recently introduced in the Lazio Region, was monitored over the season from June to September giving indications on their sensorial, pharmaceutical/nutraceutical proprieties. Both untargeted (NMR) and targeted (GC/MS, UHPLC, HPLC-PDA/FD and spectrophotometry) analyses were carried out to identify and quantify compounds of different classes (sugars, organic acids, amino acids, cannabinoids, terpenoids, phenols, tannins, flavonoids and biogenic amines). All cultivars in each harvesting period showed a THC content below the Italian legal limit, although in general THC content increased over the season. Citric acid, malic acid and glucose showed the highest content in the late flowering period, whereas the content of proline drastically decreased after June in all cultivars. Neophytadiene, nerolidol and chlorogenic acid were quantified only in Felina 32 cultivar, characterized also by a very high content of flavonoids, whereas alloaromadendrene and trans-cinnamic acid were detected only in Uso-31 cultivar. Naringenin and naringin were present only in Fedora 17 and Ferimon cultivars, respectively. Moreover, Ferimon had the highest concentration of biogenic amines, especially in July and August. Cadaverine was present in all cultivars but only in September. These results suggest that the chemical composition of Cannabis sativa L. inflorescences depends on the cultivar and on the harvesting period. Producers can use this information as a guide to obtain inflorescences with peculiar chemical characteristics according to the specific use.
- Published
- 2020
- Full Text
- View/download PDF
18. Phytocomplex Characterization and Biological Evaluation of Powdered Fruits and Leaves from Elaeagnus angustifolia
- Author
-
Simone Carradori, Francesco Cairone, Stefania Garzoli, Giancarlo Fabrizi, Antonia Iazzetti, Anna Maria Giusti, Luigi Menghini, Sengul Uysal, Gunes Ak, Gokhan Zengin, and Stefania Cesa
- Subjects
Elaeagnus angustifolia ,MW-assisted extraction ,scCO2-assisted extraction ,pigments ,polyphenols ,HS-GC/MS ,Organic chemistry ,QD241-441 - Abstract
Fully ripe fruits and mature leaves of Elaeagnus angustifolia were harvested and analyzed by means of analytical and biological tests to better comprehend the chemical composition and therapeutic/nutraceutical potential of this plant. Fruits and leaves were dried and the obtained powders were analyzed to study their color character and (via headspace gas chromatography) describe the chemical profile. Subsequently, they were submitted to a chloroform–methanol extraction, to a hydroalcoholic extraction procedure assisted or not by microwaves, and to an extraction with supercritical CO2, assisted or not by ethanol as the co-solvent, to detect the polyphenolic and the volatile content. The resulting extracts were evaluated in terms of chlorophyll and carotenoid content, polyphenolic content, volatile fraction, total phenolic content, total flavonoid content, antioxidant activity, radical scavenging activity, and enzymatic inhibition activity. The results confirmed the correlation between the chemical composition and the high antioxidant potential of leaf extracts compared to the fruit extracts in terms of the phenolic and pigment content. A promising effect against tyrosinase emerged for all the extracts, suggesting a therapeutic/nutraceutical use for this plant. Conversely, the volatile content from both natural matrices was similar.
- Published
- 2020
- Full Text
- View/download PDF
19. Untargeted NMR-Based Methodology in the Study of Fruit Metabolites
- Author
-
Anatoly Petrovich Sobolev, Luisa Mannina, Noemi Proietti, Simone Carradori, Maria Daglia, Anna Maria Giusti, Riccarda Antiochia, and Donatella Capitani
- Subjects
NMR ,fruits ,metabolomics ,primary metabolites ,secondary metabolites ,Organic chemistry ,QD241-441 - Abstract
In this review, fundamental aspects of the untargeted NMR-based methodology applied to fruit characterization are described. The strategy to perform the structure elucidation of fruit metabolites is discussed with some examples of spectral assignments by 2D experiments. Primary ubiquitous metabolites as well as secondary species-specific metabolites, identified in different fruits using an untargeted 1H-NMR approach, are summarized in a comprehensive way. Crucial aspects regarding the quantitative elaboration of spectral data are also discussed. The usefulness of the NMR-based metabolic profiling was highlighted using some results regarding quality, adulteration, varieties and geographical origin of fruits and fruit-derived products such as juices.
- Published
- 2015
- Full Text
- View/download PDF
20. New Hybrid Tomato Cultivars: An NMR-Based Chemical Characterization
- Author
-
Cinzia Ingallina, Anatoly P. Sobolev, Simone Circi, Mattia Spano, Anna Maria Giusti, and Luisa Mannina
- Subjects
hybrid tomato ,1h-nmr ,metabolic profile ,Technology ,Engineering (General). Civil engineering (General) ,TA1-2040 ,Biology (General) ,QH301-705.5 ,Physics ,QC1-999 ,Chemistry ,QD1-999 - Abstract
Bamano, King Creole, Sugarland, and DulceMiel hybrid tomato cultivars have been recently introduced in the Lazio area (Central Italy) to expand and valorize the regional/national market. Tomatoes from these cultivars, together with tomatoes from the native Fiaschetta cultivar, were sampled at the proper ripening time for the fresh market and characterized to obtain and compare their metabolite profiles. The Bligh−Dyer extraction protocol was carried out, and the resulting organic and hydroalcoholic fractions were analyzed by high-field Nuclear Magnetic Resonance (NMR) spectroscopy. NMR data relative to quantified metabolites (sugars, amino acids, organic acids, sterols, and fatty acids) allowed to point out similarities and differences among cultivars. DulceMiel hybrid and Fiaschetta native cultivars showed some common aspects having the highest levels of the most abundant amino acids as well as comparable amounts of organic acids, amino acids, stigmasterol, and linoleic and linolenic acids. However, DulceMiel turned out to have higher levels of glucose, fructose, and galactose with respect to Fiaschetta, reflecting the particular taste of the DulceMiel product. King Creole, Bamano, and Sugarland hybrid cultivars were generally characterized by the lowest content of amino acids and organic acids. King Creole showed the highest content of malic acid, whereas Bamano was characterized by the highest levels of glucose and fructose.
- Published
- 2020
- Full Text
- View/download PDF
21. Blueberry-Based Meals for Obese Patients with Metabolic Syndrome: A Multidisciplinary Metabolomic Pilot Study
- Author
-
Anatoly Petrovich Sobolev, Alessandra Ciampa, Cinzia Ingallina, Luisa Mannina, Donatella Capitani, Ilaria Ernesti, Elisa Maggi, Rita Businaro, Maria Del Ben, Petra Engel, Anna Maria Giusti, Lorenzo M. Donini, and Alessandro Pinto
- Subjects
1H-NMR ,urine ,cytokines ,metabolic syndrome ,blueberries ,Microbiology ,QR1-502 - Abstract
A pilot study was carried out on five obese/overweight patients suffering from metabolic syndrome, with the aim to evaluate postprandial effects of high fat/high glycemic load meals enriched by blueberries. Postprandial urine samples were analyzed by 1H-NMR spectroscopy after 2 and 4 h from ingestion to identify potential markers of blueberry intake. Significant decrease of methylamines, acetoacetate, acetone and succinate, known indicators of type 2 diabetes mellitus, were observed after the intake of meals enriched with blueberries. On the other hand, an accumulation of p-hydroxyphenyl-acetic acid and 3-(3’-hydroxyphenyl)-3-hydropropionic acid originating from gut microbial dehydrogenation of proanthocyanidins and procyanidins was detected. Real-time PCR-analysis of mRNAs obtained from mononuclear blood cells showed significant changes in cytokine gene expression levels after meals integrated with blueberries. In particular, the mRNAs expression of interleukin-6 (IL-6) and Transforming Growth Factor-β (TGF-β), pro and anti-inflammation cytokines, respectively, significantly decreased and increased after blueberry supplementation, indicating a positive impact of blueberry ingestion in the reduction of risk of inflammation. The combined analysis of the urine metabolome and clinical markers represents a promising approach in monitoring the metabolic impact of blueberries in persons with metabolic syndrome.
- Published
- 2019
- Full Text
- View/download PDF
22. Atriplex mollis Desf. Aerial Parts: Extraction Procedures, Secondary Metabolites and Color Analysis
- Author
-
Nassima Boutaoui, Lahcene Zaiter, Fadila Benayache, Samir Benayache, Francesco Cacciagrano, Stefania Cesa, Daniela Secci, Simone Carradori, Anna Maria Giusti, Cristina Campestre, Luigi Menghini, and Marcello Locatelli
- Subjects
Atriplex mollis ,SFE ,MAE ,HPLC-PDA ,color analysis ,pigments ,Organic chemistry ,QD241-441 - Abstract
A method using high-performance liquid chromatography coupled with a photodiode array detector was proposed for the rapid characterization of different phenolic constituents from the extracts of Atriplex mollis aerial parts. Atriplex species are known for their multiple biological activities, but no information is available in the literature about A. mollis. With the aim to firstly characterize the main secondary metabolites of this plant, so as to orient better the biological evaluation, we applied three different extraction procedures and compared the chromatographic results. Microwave-assisted extraction gave the best yield and recovery of important compounds such as gallic acid, catechin, chlorogenic acid, p-OH benzoic acid, rutin, sinapinic acid, t-ferulic acid, naringenin and benzoic acid. These constituents belong to three important chemical classes: phenolic acids, flavonoids and monoterpenes. Color evaluation and analysis of chlorophylls (a and b) and carotenoids complete the preliminary profile of this plant. From these analyses, Atriplex mollis is a source of bioactive compounds (especially rutin, t-ferulic acid and gallic acid) and could be recommended as a plant of phyto-pharmaceutical relevance, opening new perspectives on this salt-tolerant plant.
- Published
- 2018
- Full Text
- View/download PDF
23. Qualitative and Quantitative Phytochemical Analysis of Different Extracts from Thymus algeriensis Aerial Parts
- Author
-
Nassima Boutaoui, Lahcene Zaiter, Fadila Benayache, Samir Benayache, Simone Carradori, Stefania Cesa, Anna Maria Giusti, Cristina Campestre, Luigi Menghini, Denise Innosa, and Marcello Locatelli
- Subjects
color analysis ,pigments ,MAE ,HPLC-PDA ,SFE ,Thymus algeriensis ,Organic chemistry ,QD241-441 - Abstract
This study was performed to evaluate the metabolite recovery from different extraction methods applied to Thymus algeriensis aerial parts. A high-performance liquid chromatographic method using photodiode array detector with gradient elution has been developed and validated for the simultaneous estimation of different phenolic compounds in the extracts and in their corresponding purified fractions. The experimental results show that microwave-assisted aqueous extraction for 15 min at 100 °C gave the most phenolics-enriched extract, reducing extraction time without degradation effects on bioactives. Sixteen compounds were identified in this extract, 11 phenolic compounds and five flavonoids, all known for their biological activities. Color analysis and determination of chlorophylls and carotenoids implemented the knowledge of the chemical profile of this plant.
- Published
- 2018
- Full Text
- View/download PDF
24. 177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice.
- Author
-
Ada H V Repetto-Llamazares, Roy H Larsen, Anna Maria Giusti, Elena Riccardi, Øyvind S Bruland, Pål Kristian Selbo, and Jostein Dahle
- Subjects
Medicine ,Science - Abstract
CD37 is an internalizing B-cell antigen expressed on Non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia cells (CLL). The anti-CD37 monoclonal antibody HH1 was conjugated to the bifunctional chelator p-SCN-Bn-DOTA and labelled with the beta-particle emitting radionuclide 177Lu creating the radio-immunoconjugate (RIC) 177Lu-DOTA-HH1 (177Lu-HH1, trade name Betalutin). The present toxicity study was performed prior to initiation of clinical studies with 177Lu-HH1.Nude mice with or without tumor xenografts were treated with 50 to 1000 MBq/kg 177Lu- HH1 and followed for clinical signs of toxicity up to ten months. Acute, life threatening bone marrow toxicity was observed in animals receiving 800 and 1000 MBq/kg 177Lu-HH1. Significant changes in serum concentrations of liver enzymes were evident for treatment with 1000 MBq/kg 177Lu-HH1. Lymphoid depletion, liver necrosis and atrophy, and interstitial cell hyperplasia of the ovaries were also observed for mice in this dose group.177Lu-DOTA-HH1 was well tolerated at dosages about 10 times above those considered relevant for radioimmunotherapy in patients with B-cell derived malignancies.The toxicity profile was as expected for RICs. Our experimental results have paved the way for clinical evaluation of 177Lu-HH1 in NHL patients.
- Published
- 2014
- Full Text
- View/download PDF
25. The influence of front-of-pack nutritional labels on eating and purchasing behaviors: a narrative review of the literature
- Author
-
Claudia Penzavecchia, Patrizia Todisco, Luca Muzzioli, Andrea Poli, Franca Marangoni, Eleonora Poggiogalle, Anna Maria Giusti, Andrea Lenzi, Alessandro Pinto, and Lorenzo Maria Donini
- Subjects
Psychiatry and Mental health ,Clinical Psychology - Abstract
Background Front-of-Pack Nutritional Labels are considered a useful tool to help consumers orient themselves in their food choices and direct their behavior toward a healthier diet. FOPNL development and use are part of a framework that includes cognitive, biological, hedonic and cultural aspects, able to affect consumers' eating and purchasing behavior. Aim Given the complexity of the matter, the aim of this narrative review is to analyze the combination of different factors that drive food choices and eating behaviors and to highlight some aspects that are not fully studied. Methods The authors conducted the research using a top-down approach at first, followed by a bottom-up approach; starting with general considerations about the purchasing process, gradually narrowing the discussion to a specific sub-population, and finally extending the discussion back to more general reasonings about the direction to adopt in future, or at least to evaluate, for effective communication. Results Biases and attitudes toward food products were found to regularly interfere with buying behavior patterns, making it impossible to standardize an average consumer. This reflects in current research, increasing the complexity of the topic. All determinants influencing food choices are often assessed individually rather than in a synergistic and multidimensional context, while the purchasing scenario is characterized by multiple stimuli to which the consumer is subjected. FOPNLs’ impact on perceived healthiness has been studied in different conditions, but some population subgroups have not been sufficiently represented. In particular, the effect of FOPNLs on consumers suffering from eating disorders is understudied and needs further attention. Furthermore, some approaches can be compared to “negative nutrition” or “loss-framed communication”, putting nutrients out of context, emphasizing losses more than gains and risking promoting negative feelings in consumers. Conclusion Due to the heterogeneity of studies, evidence on what works best in driving people to adopt lasting lifestyle changes is still mixed. Science communicators and policymakers should consider the possibility that a multi-component approach incorporating nutrition information and education may be a key strategy to promote consumers’ self-consciousness and to support them in their cognitive efforts toward a healthy and sustainable diet. Level of evidence Level V, narrative review.
- Published
- 2022
- Full Text
- View/download PDF
26. Supplementary Figures 1-6 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
- Author
-
Pablo Umaña, Christine Trumpfheller, Pedro Romero, Birgit Essig, François Christen, Thomas Emrich, Felix Weber, Sara Labiano, Whitney Jordaan, Anne Freimoser-Grundschober, Valeria Nicolini, Roberto Adelfio, Birte Appelt, Andrzej Sobieniecki, Martin Lechmann, Ulrike Hopfer, Peter Brünker, Elena Menietti, Leo Kunz, Dario Speziale, Mario Perro, Anna Maria Giusti, Harald Dürr, Marine Le Clech, Philipp Fröbel, Moritz Rapp, and Eva Sum
- Abstract
Supplementary Figure 1 shows more details on the mode of action and design of the used antibodies. Supplementary Figure 2 displays additional APC activation data of the human and murine FAP-CD40 molecules. Supplementary Figure 3 shows additional data for FRC in vitro assays and the OVA vaccination study. Supplementary Figure 4 shows additional data on the in vivo study comparing FAP-huCD40 and SGN40 moIgG1. Supplementary Figure 5 displays additional data on the in vivo comparison of selicrelumab and FAP-huCD40. Supplementary Figure 6 shows the data of a FAP-huCD40 dose escalation study in cynomolgus monkeys.
- Published
- 2023
- Full Text
- View/download PDF
27. Supplemental data from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
- Author
-
Pablo Umaña, Christian Klein, Christiane Neumann, Laurent Lariviere, Anne Freimoser-Grundschober, Anna Maria Giusti, Heather Hinton, Katharine Bray-French, Wolfgang Richter, Tamara Hüsser, Ramona Schlenker, Florian Limani, Sarah Diggelmann, Valeria Nicolini, Anne Schoenle, Marine Richard, Roberta Bianchi, Stanford Chen, Mario Perro, Johannes Sam, Sylvia Herter, Sara Colombetti, and Marina Bacac
- Abstract
Supplemental data details
- Published
- 2023
- Full Text
- View/download PDF
28. Video 3 from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
- Author
-
Pablo Umaña, Christian Klein, Christiane Neumann, Laurent Lariviere, Anne Freimoser-Grundschober, Anna Maria Giusti, Heather Hinton, Katharine Bray-French, Wolfgang Richter, Tamara Hüsser, Ramona Schlenker, Florian Limani, Sarah Diggelmann, Valeria Nicolini, Anne Schoenle, Marine Richard, Roberta Bianchi, Stanford Chen, Mario Perro, Johannes Sam, Sylvia Herter, Sara Colombetti, and Marina Bacac
- Abstract
Supplemental Video 3. In vitro visualization of the dynamics of CD20-TCB (white) during interaction between CD8+ T-cells (green) and tumor cells (blue). The video focuses on an example of CD20-TCB-mediated CD8+ T-cell cytotoxicity of tumor cells. T-cells surround the tumor cells and create stable synapses where CD20-TCB is localized (white). Tumor cells are killed upon certain time of T-cell/tumor cell interaction as evidenced by the formation of tumor blebs.
- Published
- 2023
- Full Text
- View/download PDF
29. Data from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
- Author
-
Pablo Umaña, Christine Trumpfheller, Pedro Romero, Birgit Essig, François Christen, Thomas Emrich, Felix Weber, Sara Labiano, Whitney Jordaan, Anne Freimoser-Grundschober, Valeria Nicolini, Roberto Adelfio, Birte Appelt, Andrzej Sobieniecki, Martin Lechmann, Ulrike Hopfer, Peter Brünker, Elena Menietti, Leo Kunz, Dario Speziale, Mario Perro, Anna Maria Giusti, Harald Dürr, Marine Le Clech, Philipp Fröbel, Moritz Rapp, and Eva Sum
- Abstract
Purpose:CD40 agonists hold great promise for cancer immunotherapy (CIT) as they enhance dendritic cell (DC) activation and concomitant tumor-specific T-cell priming. However, the broad expression of CD40 accounts for sink and side effects, hampering the efficacy of anti-CD40 antibodies. We hypothesized that these limitations can be overcome by selectively targeting CD40 agonism to the tumor. Therefore, we developed a bispecific FAP-CD40 antibody, which induces CD40 stimulation solely in presence of fibroblast activation protein α (FAP), a protease specifically expressed in the tumor stroma.Experimental Design:FAP-CD40's in vitro activity and FAP specificity were validated by antigen-presenting cell (APC) activation and T-cell priming assays. In addition, FAP-CD40 was tested in subcutaneous MC38-FAP and KPC-4662-huCEA murine tumor models.Results:FAP-CD40 triggered a potent, strictly FAP-dependent CD40 stimulation in vitro. In vivo, FAP-CD40 strongly enhanced T-cell inflammation and growth inhibition of KPC-4662-huCEA tumors. Unlike nontargeted CD40 agonists, FAP-CD40 mediated complete regression of MC38-FAP tumors, entailing long-term protection. A high dose of FAP-CD40 was indispensable for these effects. While nontargeted CD40 agonists induced substantial side effects, highly dosed FAP-CD40 was well tolerated. FAP-CD40 preferentially accumulated in the tumor, inducing predominantly intratumoral immune activation, whereas nontargeted CD40 agonists displayed strong systemic but limited intratumoral effects.Conclusions:FAP-CD40 abrogates the systemic toxicity associated with nontargeted CD40 agonists. This enables administration of high doses, essential for overcoming CD40 sink effects and inducing antitumor immunity. Consequently, FAP-targeted CD40 agonism represents a promising strategy to exploit the full potential of CD40 signaling for CIT.
- Published
- 2023
- Full Text
- View/download PDF
30. Supplemental figures from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
- Author
-
Pablo Umaña, Christian Klein, Christiane Neumann, Laurent Lariviere, Anne Freimoser-Grundschober, Anna Maria Giusti, Heather Hinton, Katharine Bray-French, Wolfgang Richter, Tamara Hüsser, Ramona Schlenker, Florian Limani, Sarah Diggelmann, Valeria Nicolini, Anne Schoenle, Marine Richard, Roberta Bianchi, Stanford Chen, Mario Perro, Johannes Sam, Sylvia Herter, Sara Colombetti, and Marina Bacac
- Abstract
Supplemental Figure 1. Assessment of the binding characteristics and cynomolgus monkey cross-reactivity of CD20-TCB. Supplemental Figure 2. Tumor cell lysis mediated by different CD20-targeting TCB antibodies. Supplemental Figure 3. T-cell and B-cell counts along with E:T ratio upon CD20-TCB treatment of primary bone marrow aspirates from patients with lymphoma and leukemia. Supplemental Figure 4. Quantification of interactions between T-cells and tumor cells from live imaging experiments and kinetic analysis of T-cell activation and exhaustion marker expression. Supplemental Figure 5. Secretion of cytokines, cytotoxic granules and T-cell proliferation upon tumor lysis. Supplemental Figure 6. Assessment of the cytokine-mediated endothelial cell activation. Supplemental Figure 7. Characterization of stem cell humanized mice (HSC-NSG) generated in house.
- Published
- 2023
- Full Text
- View/download PDF
31. Supplementary Table 1 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
- Author
-
Pablo Umaña, Christine Trumpfheller, Pedro Romero, Birgit Essig, François Christen, Thomas Emrich, Felix Weber, Sara Labiano, Whitney Jordaan, Anne Freimoser-Grundschober, Valeria Nicolini, Roberto Adelfio, Birte Appelt, Andrzej Sobieniecki, Martin Lechmann, Ulrike Hopfer, Peter Brünker, Elena Menietti, Leo Kunz, Dario Speziale, Mario Perro, Anna Maria Giusti, Harald Dürr, Marine Le Clech, Philipp Fröbel, Moritz Rapp, and Eva Sum
- Abstract
List of antibodies used for flow cytometry
- Published
- 2023
- Full Text
- View/download PDF
32. Video 1 from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
- Author
-
Pablo Umaña, Christian Klein, Christiane Neumann, Laurent Lariviere, Anne Freimoser-Grundschober, Anna Maria Giusti, Heather Hinton, Katharine Bray-French, Wolfgang Richter, Tamara Hüsser, Ramona Schlenker, Florian Limani, Sarah Diggelmann, Valeria Nicolini, Anne Schoenle, Marine Richard, Roberta Bianchi, Stanford Chen, Mario Perro, Johannes Sam, Sylvia Herter, Sara Colombetti, and Marina Bacac
- Abstract
Supplemental Video 1. In vitro visualization of the dynamics of untargeted TCB (white) during the interaction between CD8+ T-cells (green) and tumor cells (blue).
- Published
- 2023
- Full Text
- View/download PDF
33. Supplementary material and methods from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
- Author
-
Pablo Umaña, Christine Trumpfheller, Pedro Romero, Birgit Essig, François Christen, Thomas Emrich, Felix Weber, Sara Labiano, Whitney Jordaan, Anne Freimoser-Grundschober, Valeria Nicolini, Roberto Adelfio, Birte Appelt, Andrzej Sobieniecki, Martin Lechmann, Ulrike Hopfer, Peter Brünker, Elena Menietti, Leo Kunz, Dario Speziale, Mario Perro, Anna Maria Giusti, Harald Dürr, Marine Le Clech, Philipp Fröbel, Moritz Rapp, and Eva Sum
- Abstract
Additional details on methods used for SPR assays, NanoString RNAseq and cynomolgus monkey studies
- Published
- 2023
- Full Text
- View/download PDF
34. Data from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
- Author
-
Pablo Umaña, Christian Klein, Christiane Neumann, Laurent Lariviere, Anne Freimoser-Grundschober, Anna Maria Giusti, Heather Hinton, Katharine Bray-French, Wolfgang Richter, Tamara Hüsser, Ramona Schlenker, Florian Limani, Sarah Diggelmann, Valeria Nicolini, Anne Schoenle, Marine Richard, Roberta Bianchi, Stanford Chen, Mario Perro, Johannes Sam, Sylvia Herter, Sara Colombetti, and Marina Bacac
- Abstract
Purpose: Despite promising clinical activity, T-cell–engaging therapies including T-cell bispecific antibodies (TCB) are associated with severe side effects requiring the use of step-up-dosing (SUD) regimens to mitigate safety. Here, we present a next-generation CD20-targeting TCB (CD20-TCB) with significantly higher potency and a novel approach enabling safer administration of such potent drug.Experimental Design: We developed CD20-TCB based on the 2:1 TCB molecular format and characterized its activity preclinically. We also applied a single administration of obinutuzumab (Gazyva pretreatment, Gpt; Genentech/Roche) prior to the first infusion of CD20-TCB as a way to safely administer such a potent drug.Results: CD20-TCB is associated with a long half-life and high potency enabled by high-avidity bivalent binding to CD20 and head-to-tail orientation of B- and T-cell–binding domains in a 2:1 molecular format. CD20-TCB displays considerably higher potency than other CD20-TCB antibodies in clinical development and is efficacious on tumor cells expressing low levels of CD20. CD20-TCB also displays potent activity in primary tumor samples with low effector:target ratios. In vivo, CD20-TCB regresses established tumors of aggressive lymphoma models. Gpt enables profound B-cell depletion in peripheral blood and secondary lymphoid organs and reduces T-cell activation and cytokine release in the peripheral blood, thus increasing the safety of CD20-TCB administration. Gpt is more efficacious and safer than SUD.Conclusions: CD20-TCB and Gpt represent a potent and safer approach for treatment of lymphoma patients and are currently being evaluated in phase I, multicenter study in patients with relapsed/refractory non-Hodgkin lymphoma (NCT03075696). Clin Cancer Res; 24(19); 4785–97. ©2018 AACR.See related commentary by Prakash and Diefenbach, p. 4631
- Published
- 2023
- Full Text
- View/download PDF
35. Supplementary Table 2 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
- Author
-
Pablo Umaña, Christine Trumpfheller, Pedro Romero, Birgit Essig, François Christen, Thomas Emrich, Felix Weber, Sara Labiano, Whitney Jordaan, Anne Freimoser-Grundschober, Valeria Nicolini, Roberto Adelfio, Birte Appelt, Andrzej Sobieniecki, Martin Lechmann, Ulrike Hopfer, Peter Brünker, Elena Menietti, Leo Kunz, Dario Speziale, Mario Perro, Anna Maria Giusti, Harald Dürr, Marine Le Clech, Philipp Fröbel, Moritz Rapp, and Eva Sum
- Abstract
List of all genes analyzed in NanoString gene expression analysis comparing gene expression in tumors of selicrelumab and FAP-huCD40-treated mice
- Published
- 2023
- Full Text
- View/download PDF
36. Supplementary Table 3 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
- Author
-
Pablo Umaña, Christine Trumpfheller, Pedro Romero, Birgit Essig, François Christen, Thomas Emrich, Felix Weber, Sara Labiano, Whitney Jordaan, Anne Freimoser-Grundschober, Valeria Nicolini, Roberto Adelfio, Birte Appelt, Andrzej Sobieniecki, Martin Lechmann, Ulrike Hopfer, Peter Brünker, Elena Menietti, Leo Kunz, Dario Speziale, Mario Perro, Anna Maria Giusti, Harald Dürr, Marine Le Clech, Philipp Fröbel, Moritz Rapp, and Eva Sum
- Abstract
Additional data of cynomolgus monkey study showing body weight and plasma cytokine levels over the course of the study
- Published
- 2023
- Full Text
- View/download PDF
37. Video 2 from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
- Author
-
Pablo Umaña, Christian Klein, Christiane Neumann, Laurent Lariviere, Anne Freimoser-Grundschober, Anna Maria Giusti, Heather Hinton, Katharine Bray-French, Wolfgang Richter, Tamara Hüsser, Ramona Schlenker, Florian Limani, Sarah Diggelmann, Valeria Nicolini, Anne Schoenle, Marine Richard, Roberta Bianchi, Stanford Chen, Mario Perro, Johannes Sam, Sylvia Herter, Sara Colombetti, and Marina Bacac
- Abstract
Supplemental Video 2. In vitro visualization of the dynamics of CD20-TCB (white) during the interaction between CD8+ T-cells (green) and tumor cells (blue).
- Published
- 2023
- Full Text
- View/download PDF
38. Supplemental methods from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
- Author
-
Pablo Umaña, Christian Klein, Christiane Neumann, Laurent Lariviere, Anne Freimoser-Grundschober, Anna Maria Giusti, Heather Hinton, Katharine Bray-French, Wolfgang Richter, Tamara Hüsser, Ramona Schlenker, Florian Limani, Sarah Diggelmann, Valeria Nicolini, Anne Schoenle, Marine Richard, Roberta Bianchi, Stanford Chen, Mario Perro, Johannes Sam, Sylvia Herter, Sara Colombetti, and Marina Bacac
- Abstract
Supplemental materials and methods
- Published
- 2023
- Full Text
- View/download PDF
39. Supplemental Tables from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
- Author
-
Pablo Umaña, Christian Klein, Christiane Neumann, Laurent Lariviere, Anne Freimoser-Grundschober, Anna Maria Giusti, Heather Hinton, Katharine Bray-French, Wolfgang Richter, Tamara Hüsser, Ramona Schlenker, Florian Limani, Sarah Diggelmann, Valeria Nicolini, Anne Schoenle, Marine Richard, Roberta Bianchi, Stanford Chen, Mario Perro, Johannes Sam, Sylvia Herter, Sara Colombetti, and Marina Bacac
- Abstract
Supplemental Table 1. Overview of CD20-targeting T-cell bispecific molecules evaluated in the current study. Supplemental Table 2. Tumor cell lines and EC50 values of tumor cell lysis. Supplemental Table 3. Assessment of the activity in ex vivo primary tumor samples derived from aggressive lymphoma and leukemia patients. Supplemental Table 4. Absolute values of cytokines measured by multiplex analysis of blood samples reported as heatmap in Figure 3e, 4b, 5d, and 6b. Supplemental Table 5. Average score of perivascular CD3 positive T-cells in the lung (assessed by blinded pathologist analysis) referring to T-cell staining of lungs from tumor-bearing, HSC NSG mice 7 days after the first treatment and 24 h after the second treatment (treatment groups are indicated on Figure 6D panels).
- Published
- 2023
- Full Text
- View/download PDF
40. Industrial Hemp (
- Author
-
Mattia, Spano, Giacomo, Di Matteo, Cinzia, Ingallina, Anatoly Petrovich, Sobolev, Anna Maria, Giusti, Giuliana, Vinci, Silvia, Cammarone, Carola, Tortora, Lara, Lamelza, Sabrina Antonia, Prencipe, Laura, Gobbi, Bruno, Botta, Federico, Marini, Enio, Campiglia, and Luisa, Mannina
- Abstract
In this study, the effect of several agronomical practices on the chemical composition of hemp inflorescences, a potential novel food that needs to be further studied, was observed. Here, the case study of inflorescences from Ferimon cultivars is discussed and submitted to different agronomical practices (irrigation and fertilizers) in different years, and the inflorescences harvested in different periods were analyzed by a multimethodological approach. Targeted and untargeted methodologies allowed cannabinoids, total phenolic content, metabolite profile and antioxidant activity to be determined. The biomass and inflorescence yields were also reported. The whole data set was submitted to ANOVA-simultaneous component analysis. The statistic results allowed us to observe that irrigation was responsible for the (-)-Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) increment. THC, cannabichromene (CBC), cannabigerol (CBG), succinate, and fructose resulted as higher in full female flowering than in the period of seed maturity. On the other hand, nitrogen supplementation led to an increase of iso-leucine, valine, and threonine. The obtained results underlined both the potential food application of hemp inflorescences, due to the rich chemical profile, and the strong effect of agronomical practices, mainly irrigation and harvesting, on the qualitative and quantitative characteristics of its metabolite profile.
- Published
- 2022
41. ROCKETS - a novel one-for-all toolbox for light sheet microscopy in drug discovery
- Author
-
Joerg PJ Mueller, Michael Dobosz, Nils O’Brien, Anna Maria Giusti, Martin Lechmann, Franz Osl, Ann-Katrin Wolf, Markus Sauer, Frank Herting, Pablo Umana, Sara Colombetti, Thomas Pöschinger, and Andreas Beilhack
- Abstract
Advancing novel immunotherapy strategies requires refined tools in preclinical research to thoroughly assess drug targets, biodistribution, safety, and efficacy. Light sheet fluorescence microscopy (LSFM) offers unprecedented fast volumetric ex vivo imaging of large tissue samples in high resolution. Yet, to date laborious and unstandardized tissue processing procedures have limited throughput and broader applications in immunological research. Therefore, we have developed a simple and harmonized protocol for processing, clearing and imaging of all mouse organs and even entire mouse bodies. Applying this Rapid Optical Clearing Kit for Enhanced Tissue Scanning (ROCKETS) in combination with LSFM allowed us to comprehensively study the in vivo biodistribution of an antibody targeting Epithelial Cell Adhesion Molecule (EpCAM) in 3D. Quantitative high-resolution scans of whole organs did not only reveal known EpCAM expression patterns but, importantly, uncovered several new EpCAM-binding sites. We identified choroid plexi in the brain and duodenal papillae as unexpected locations of high EpCAM-expression. These tissue locations may be considered as particularly sensitive sites due their importance for liquor production or as critical junctions draining bile and digestive pancreatic enzymes into the small bowel, respectively. These newly gained insights appear highly relevant for clinical translation of EpCAM-addressing immunotherapies. Thus, ROCKETS in combination with LSFM may help to set new standards for preclinical evaluation of immunotherapeutic strategies. Conclusively, we propose ROCKETS as an ideal platform for a broader application of LSFM in immunological research optimally suited for quantitative co-localization studies of immunotherapeutic drugs and defined cell populations in the microanatomical context of organs or even whole mice.
- Published
- 2022
- Full Text
- View/download PDF
42. Predicting Myelosuppression of Drugs from in Silico Models.
- Author
-
Patrizia Crivori, Giulia Pennella, Miriam Magistrelli, Pietro Grossi, and Anna Maria Giusti
- Published
- 2011
- Full Text
- View/download PDF
43. Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophils
- Author
-
Gabrielle Leclercq, Llucia Alberti Servera, Sabrina Danilin, John Challier, Nathalie Steinhoff, Claudia Bossen, Alex Odermatt, Valeria Nicolini, Pablo Umaña, Christian Klein, Marina Bacac, Anna-Maria Giusti, Anneliese Schneider, and Hélène Haegel
- Subjects
Oncology ,Neutrophils ,T-Lymphocytes ,Antibodies, Bispecific ,Immunology ,Cytokines ,Humans ,Immunology and Allergy ,Cytokine Release Syndrome - Abstract
T cell engagers represent a novel promising class of cancer-immunotherapies redirecting T cells to tumor cells and have some promising outcomes in the clinic. These molecules can be associated with a mode-of-action related risk of cytokine release syndrome (CRS) in patients. CRS is characterized by the rapid release of pro-inflammatory cytokines such as TNF-α, IFN-γ, IL-6 and IL-1β and immune cell activation eliciting clinical symptoms of fever, hypoxia and hypotension. In this work, we investigated the biological mechanisms triggering and amplifying cytokine release after treatment with T cell bispecific antibodies (TCBs) employing an
- Published
- 2022
- Full Text
- View/download PDF
44. Efficacy of front-of-pack nutrition labels in improving health status
- Author
-
Lorenzo Maria Donini, Claudia Penzavecchia, Luca Muzzioli, Eleonora Poggiogalle, Anna Maria Giusti, Andrea Lenzi, and Alessandro Pinto
- Subjects
Nutrition and Dietetics ,Food Labeling ,Endocrinology, Diabetes and Metabolism ,Humans ,Nutritional Status ,Obesity ,Consumer Behavior ,Diet, Healthy ,Noncommunicable Diseases ,Nutritive Value - Abstract
Nutrition labels advise consumers about the nutritional value of packaged foods and their contribution to the overall composition of the diet. They have been proposed as an instrument for the promotion of healthy diets and as a fundamental tool in the prevention of obesity and diet-related non-communicable diseases (NCDs). The aim of this review is to discuss the effectiveness of front-of-pack nutrition labels (FOPNLs) in improving health status, the concern about focusing on single nutrients/foods rather than on eating patterns to prevent obesity and NCDs, and the strength of positive rather than negative messages to promote a healthy and sustainable diet. Although nutrition science investigates individual foods or nutrients, when communicating to the public most of the significant evidence of the favorable health effect largely depends on dietary patterns and not on a single food component or individual nutrient. Therefore, we suggest that a new tool based on positive communication should be developed and implemented to highlight the importance of the diet as a complex matrix.
- Published
- 2022
45. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food
- Author
-
Donatella Ambroselli, Fabrizio Masciulli, Enrico Romano, Giuseppina Catanzaro, Zein Mersini Besharat, Maria Chiara Massari, Elisabetta Ferretti, Silvia Migliaccio, Luana Izzo, Alberto Ritieni, Michela Grosso, Caterina Formichi, Francesco Dotta, Francesco Frigerio, Eleonora Barbiera, Anna Maria Giusti, Cinzia Ingallina, and Luisa Mannina
- Subjects
Nutrition and Dietetics ,Food Science - Abstract
The definition of metabolic syndrome (MetS) has undergone several changes over the years due to the difficulty in establishing universal criteria for it. Underlying the disorders related to MetS is almost invariably a pro-inflammatory state related to altered glucose metabolism, which could lead to elevated cardiovascular risk. Indeed, the complications closely related to MetS are cardiovascular diseases (CVDs) and type 2 diabetes (T2D). It has been observed that the predisposition to metabolic syndrome is modulated by complex interactions between human microbiota, genetic factors, and diet. This review provides a summary of the last decade of literature related to three principal aspects of MetS: (i) the syndrome’s definition and classification, pathophysiology, and treatment approaches; (ii) prediction and diagnosis underlying the biomarkers identified by means of advanced methodologies (NMR, LC/GC-MS, and LC, LC-MS); and (iii) the role of foods and food components in prevention and/or treatment of MetS, demonstrating a possible role of specific foods intake in the development of MetS.
- Published
- 2023
- Full Text
- View/download PDF
46. Characterization of the Phytochemical Composition and Bioactivities of
- Author
-
Saida, Sissi, Silvia, Di Giacomo, Claudio, Ferrante, Paola, Angelini, Alberto, Macone, Anna Maria, Giusti, Chiara, Toniolo, Annabella, Vitalone, Aghraz, Abdellah, Mustapha, Larhsini, Luigi, Menghini, Mohammed, Markouk, Gabriela, Mazzanti, and Antonella, Di Sotto
- Subjects
Flavonoids ,Morocco ,Plant Extracts ,Phytochemicals ,Polyphenols ,Microbial Sensitivity Tests ,Asteraceae ,Plant Components, Aerial ,Tannins ,Antioxidants ,Anti-Bacterial Agents - Abstract
In the present study, the phytochemical composition and bioactivities of
- Published
- 2021
47. JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy
- Author
-
Gabrielle Leclercq, Hélène Haegel, Alberto Toso, Tina Zimmermann, Luke Green, Nathalie Steinhoff, Johannes Sam, Vesna Pulko, Anneliese Schneider, Anna Maria Giusti, John Challier, Anne Freimoser-Grundschober, Laurent Larivière, Alex Odermatt, Martin Stern, Pablo Umana, Marina Bacac, and Christian Klein
- Subjects
Pharmacology ,Clinical/Translational Cancer Immunotherapy ,Cancer Research ,Immunology ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,MTOR Inhibitors ,cytokines ,Mice ,Oncology ,Antibodies, Bispecific ,Molecular Medicine ,Immunology and Allergy ,Animals ,Humans ,Janus Kinase Inhibitors ,immunotherapy ,RC254-282 ,T-lymphocytes - Abstract
BackgroundT cell engaging therapies, like chimeric antigen receptor T cells and T cell bispecific antibodies (TCBs), efficiently redirect T cells towards tumor cells, facilitating the formation of a cytotoxic synapse and resulting in subsequent tumor cell killing, a process that is accompanied by the release of cytokines. Despite their promising efficacy in the clinic, treatment with TCBs is associated with a risk of cytokine release syndrome (CRS). The aim of this study was to identify small molecules able to mitigate cytokine release while retaining T cell-mediated tumor killing.MethodsBy screening a library of 52 Food and Drug Administration approved kinase inhibitors for their impact on T cell proliferation and cytokine release after CD3 stimulation, we identified mTOR, JAK and Src kinases inhibitors as potential candidates to modulate TCB-mediated cytokine release at pharmacologically active doses. Using an in vitro model of target cell killing by human peripheral blood mononuclear cells, we assessed the effects of mTOR, JAK and Src kinase inhibitors combined with 2+1 T cell bispecific antibodies (TCBs) including CEA-TCB and CD19-TCB on T cell activation, proliferation and target cell killing measured by flow cytometry and cytokine release measured by Luminex. The combination of mTOR, JAK and Src kinase inhibitors together with CD19-TCB was evaluated in vivo in non-tumor bearing stem cell humanized NSG mice in terms of B cell depletion and in a lymphoma patient-derived xenograft (PDX) model in humanized NSG mice in terms of antitumor efficacy.ResultsThe effect of Src inhibitors differed from those of mTOR and JAK inhibitors with the suppression of CD19-TCB-induced tumor cell lysis in vitro, whereas mTOR and JAK inhibitors primarily affected TCB-mediated cytokine release. Importantly, we confirmed in vivo that Src, JAK and mTOR inhibitors strongly reduced CD19-TCB-induced cytokine release. In humanized NSG mice, continuous treatment with a Src inhibitor prevented CD19-TCB-mediated B cell depletion in contrast to mTOR and JAK inhibitors, which retained CD19-TCB efficacy. Ultimately, transient treatment with Src, mTOR and JAK inhibitors minimally interfered with antitumor efficacy in a lymphoma PDX model.ConclusionsTaken together, these data support further evaluation of the use of Src, JAK and mTOR inhibitors as prophylactic treatment to prevent occurrence of CRS.
- Published
- 2021
48. P09.01 The use of FDA approved JAK, mTOR and Src inhibitors to regulate T cell-bispecific antibody-induced cytokine release while not preventing T cell cytotoxicity
- Author
-
Anna Maria Giusti, A Toso, Helene Haegel, Nathalie Steinhoff, T Zimmermann, Luke Green, Gabrielle Leclercq, Marina Bacac, Christian Klein, P. Umana, Anneliese Schneider, Vesna Pulko, and Johannes Sam
- Subjects
business.industry ,medicine.medical_treatment ,T cell ,medicine.disease ,Dasatinib ,Cytokine release syndrome ,Cell killing ,Cytokine ,medicine.anatomical_structure ,Sirolimus ,medicine ,Cancer research ,business ,Tyrosine kinase ,Proto-oncogene tyrosine-protein kinase Src ,medicine.drug - Abstract
Background T cell bispecific antibodies (TCBs) are potent T cell engagers, harboring a 2+1 format with one binder to the CD3e chain and two binders to specific tumor antigens. Crosslinking of CD3 with tumor antigens triggers T cell activation and proliferation, cytokine release and tumor cell killing. TCB treatment is sometimes associated with safety liabilities due to on-target on-tumor or on-target off-tumor cytotoxicity and cytokine release. Off-tumor activity of the TCB may occur if the targeted tumor antigens are expressed on healthy cells, which may potentially result in tissue damages and compromise the patient’s safety. Patients treated with TCBs may also experience a Cytokine Release Syndrome (CRS), characterized by fever, hypotension and respiratory deficiency and associated with the release of pro-inflammatory cytokines such as IL-6, TNF-α, IFN-γ, and IL-1β. Tyrosine kinases such as Src, mTOR and JAK1/2 are involved in downstream signaling pathways after engagement of the T cell receptor. Materials and Methods 52 FDA approved kinase inhibitors were screened in the presence of T cells activated on CD3 coated plates, mimicking TCB stimulation. Src, mTOR and JAK inhibitors were selected based on their capacity to prevent both, cytokine release and T cell proliferation. Using an in vitro model of target cell killing by human peripheral blood mononuclear cells stimulated with TCBs, we validated the effects of mTOR, JAK and Src kinase inhibitors on TCB-induced T cell activation, tumor cell killing and cytokine release. In vivo, the effect of mTOR, JAK and Src kinase inhibitors on TCB-induced cytokine release was confirmed in humanized NOD scid gamma (NSG) mice engrafted with human hematopoietic stem cells and treated with CD19-TCB. Results In line with previous reports for CAR-T cells, dasatinib (a src inhibitor) was found to fully switch off TCB-induced T cell functionality as well as the other src inhibitors bosutinib and ponatinib. In contrast, temsirolimus, sirolimus and everolimus (mTOR inhibitors) and ruxolitinib, baricitinib, tofacitinib, and fedratinib (JAK1/2 inhibitors) were found to more potently prevent TCB-induced cytokine release without blocking TCB-mediated target cell killing. Conclusions These results provide evidence that the mechanisms of TCB-dependent cytokine release and tumor cell killing can be uncoupled. The FDA-approved mTOR and JAK1/2 inhibitors could potentially be used to mitigate CRS whereas the Src inhibitor dasatinib could rather stand as a potential antidote for on-target off-tumor activity or high-grade CRS. Disclosure Information G. Leclercq: A. Employment (full or part-time); Modest; Roche. E. Ownership Interest (stock, stock options, patent or other intellectual property); Modest; Roche. H. Haegel: A. Employment (full or part-time); Modest; Roche. E. Ownership Interest (stock, stock options, patent or other intellectual property); Modest; Roche. A. Schneider: A. Employment (full or part-time); Modest; Roche. A. Giusti: A. Employment (full or part-time); Modest; Roche. V. Pulko: A. Employment (full or part-time); Modest; Roche. A. Toso: A. Employment (full or part-time); Modest; Roche. T. Zimmermann: A. Employment (full or part-time); Modest; Roche. L. Green: A. Employment (full or part-time); Modest; Roche. N. Steinhoff: A. Employment (full or part-time); Modest; Roche. J. Sam: A. Employment (full or part-time); Modest; Roche. M. Bacac: A. Employment (full or part-time); Modest; Roche. E. Ownership Interest (stock, stock options, patent or other intellectual property); Modest; Roche. P. Umana: A. Employment (full or part-time); Modest; Roche. E. Ownership Interest (stock, stock options, patent or other intellectual property); Modest; Roche. C. Klein: A. Employment (full or part-time); Modest; Roche. E. Ownership Interest (stock, stock options, patent or other intellectual property); Modest; Roche.
- Published
- 2021
- Full Text
- View/download PDF
49. Commercial Bio-Packaging to Preserve the Quality and Extend the Shelf-Life of Vegetables: The Case-Study of Pumpkin Samples Studied by a Multimethodological Approach
- Author
-
Giuliana Vinci, Matteo Sambucci, Jacopo Tirillò, Anna Maria Giusti, L. Gobbi, Andrea Salvo, Paola Di Matteo, Noemi Proietti, Valeria Di Tullio, Anatoly P. Sobolev, Giacomo Di Matteo, Marco Valente, Cinzia Ingallina, Paola Russo, Mattia Spano, Luisa Mannina, and Sabrina Antonia Prencipe
- Subjects
mechanical characterization ,Health (social science) ,Sucrose ,Cellophane ,biogenic amines ,Plant Science ,TP1-1185 ,engineering.material ,Shelf life ,Health Professions (miscellaneous) ,Microbiology ,Article ,biofilm ,law.invention ,chemistry.chemical_compound ,NMR spectroscopy ,Polylactic acid ,pumpkin ,shelf life ,metabolomics ,NMR relaxometry ,SPME-GC-MS analysis ,microbiological analysis ,law ,Food science ,Pulp (paper) ,Chemical technology ,Biofilm ,food and beverages ,Lactic acid ,chemistry ,engineering ,Malic acid ,Food Science - Abstract
A multidisciplinary protocol is proposed to monitor the preservation of fresh pumpkin samples (FP) using three commercial polymeric films: A made of biodegradable cellophane from regenerated cellulose pulp, B from corn starch, cassava and eucalyptus, C made of polylactic acid from corn starch, and a polyethylene film used as reference (REF). Chemical, mechanical and microbiological analyses were applied on packaging and fresh and packaged samples at different times. After an 11-day period, NMR spectroscopy results showed a sucrose increase and a malic acid decrease in all the biofilms with respect to FP, fructose, glucose, galactose levels remained quite constant in biofilms B and C, the most abundant amino acids remained quite constant in biofilm A and decreased significantly in biofilm B. From microbiological analyses total microbial count was below the threshold value up to 7 days for samples in all the films, and 11 days for biofilm C. The lactic acid bacteria, and yeasts and molds counts were below the acceptability limit during the 11 days for all packages. In the case of biofilm C, the most promising packaging for microbiological point of view, aroma analysis was also carried out. In this paper, you can find all the analysis performed and all the values found.
- Published
- 2021
50. Author response: Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies
- Author
-
Anne Freimoser-Grundschober, Ekaterina Breous-Nystrom, Heather Shannon Grant, Chaitra Belgur, Carina Hage, Anna Maria Giusti, Régine Gérard, Patrick Ray Ng, Martina Geiger, Lauriane Cabon, Adrian Roth, Katia Karalis, Nikolce Gjorevski, Tanja Fauti, Dimitris V. Manatakis, Johannes Sam, Christian Klein, William Tien-Street, Tina Weinzierl, Virginie Micallef, Thomas Singer, Anneliese Schneider, Debora B. Petropolis, Annie Moisan, Peter Bruenker, Jan Eckmann, Geraldine A. Hamilton, S. Jordan Kerns, Cristina Bertinetti-Lapatki, Riccardo Barrile, Michael Bscheider, Marina Bacac, and Marianne Kanellias
- Subjects
Profiling (computer programming) ,Bispecific antibody ,medicine.anatomical_structure ,business.industry ,T cell ,Cancer research ,medicine ,business ,Tumor targeted - Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.